U.S. Markets open in 7 mins.

ECO Animal Health Group plc (EAH.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
632.500.00 (0.00%)
As of 4:30PM BST. Market open.

ECO Animal Health Group plc

78 Coombe Road
New Malden KT3 4QS
United Kingdom
44 20 8336 2900

IndustryDrug Manufacturers - Major
Full Time Employees201

Key Executives

Mr. Marc Denham Loomes BVSc, MRCVSCEO & Exec. DirectorN/AN/A56
Mr. Kevin Anthony Stockdale BSc, ACAFin. Director & Exec. DirectorN/AN/A52
Mr. Brett Clemo BA (Hons)Exec. DirectorN/AN/AN/A
Mrs. Julia TrouseSec. & Exec. DirectorN/AN/AN/A
Mr. Peter A. Lawrence B Eng (Hons), C Eng, MBA, MSc, BSc, DIC, ACGIExec. Chairman62.24kN/A68
Amounts are as of December 31, 2005 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.


ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. The company was founded in 1972 and is headquartered in New Malden, the United Kingdom.

Corporate Governance

ECO Animal Health Group plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.